首页> 外文期刊>Journal of tissue engineering and regenerative medicine >Comparing the osteogenic potential of bone marrow and tendon-derived stromal cells to repair a critical-sized defect in the rat femur
【24h】

Comparing the osteogenic potential of bone marrow and tendon-derived stromal cells to repair a critical-sized defect in the rat femur

机译:比较骨髓和肌腱衍生的基质细胞的成骨潜力在大鼠股骨中修复临界缺陷

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Despite significant advancements in bone tissue-engineering applications, the clinical impact of bone marrow stromal cells (BMSCs) for the treatment of large osseous defects remains limited. Therefore, other cell sources are under investigation for their osteogenic potential to repair bone. In this study, tendon-derived stromal cells (TDSCs) were evaluated in comparison to BMSCs to support the functional repair of a 5mm critical-sized, segmental defect in the rat femur. Analysis of the trilineage differentiation capacity of TDSCs and BMSCs cultured on collagen sponges revealed impaired osteogenic differentiation and mineral deposition of TDSCs in vitro, whereas chondrogenic and adipogenic differentiation was evident for both cell types. Radiographic assessment demonstrated that neither cell type significantly improved the healing rate of a challenging 5mm segmental femoral defect. Transplanted TDSCs and BMSCs both led to the formation of only small amounts of bone in the defect area, and histological evaluation revealed non-mineralized, collagen-rich scar tissue to be present within the defect area. Newly formed lamellar bone was restricted to the defect margins, resulting in closure of the medullary cavity. Interestingly, in comparison to BMSCs, significantly more TDSC-derived cells were present at the osteotomy gap up to 8weeks after transplantation and were also found to be located within newly formed lamellar bone, suggesting their capacity to directly contribute to de novo bone formation. To our knowledge, this is the first study investigating the in vivo capacity of TDSCs to regenerate a critical-sized defect in the rat femur. Copyright (c) 2015 John Wiley & Sons, Ltd.
机译:尽管骨组织工程应用中具有显着的进展,但骨髓基质细胞(BMSCs)对大骨质缺陷治疗的临床影响仍然有限。因此,其他细胞源正在研究其对骨骼的骨质原性潜力。在该研究中,与BMSCS相比,评价肌腱衍生的基质细胞(TDSC),以支持大鼠股骨中的5mm临界缺陷的功能修复。对胶原海绵培养的TDSCS和BMSCs的Triliinege分化能力分析显示出体外骨质发生分化和Tdscs的矿物质沉积受损,而两种细胞类型都显而易见。放射图表评估证明,既不明显改善了挑战5mm节段性股骨缺陷的愈合率。移植的TDSCS和BMSC都导致缺陷区域中仅形成少量骨骼,而组织学评价显示出非矿化,富含胶原蛋白的瘢痕组织以存在于缺陷区域内。新成形的层状骨限制为缺陷余量,导致髓腔闭合。有趣的是,与BMSCs相比,在移植后的截骨术间隙高达8周的截骨间隙差距中,也发现更高的TDSC衍生的细胞在新形成的层状骨内,表明其直接有助于De Novo骨形成的能力。为了我们的知识,这是第一次调查TDSC体内体内能力,以重新制定大鼠股骨的关键缺陷。版权所有(c)2015 John Wiley&Sons,Ltd。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号